Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05895071Phase 1Completed
Phase 1, randomised, double-blind trial of potassium hydroxide in flat warts (2 arms), sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Comparative Efficacy of topical 5% Potassium hydroxide and liquid nitrogen at 12 weeks. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05895071.